State supreme court rules in favor of Eli Lilly in case over warning patients of risks when DTC ads are in play

In a contentious case centering on product liability, Washington state’s top court recently ruled that Eli Lilly and other drugmakers do not need to provide specific warnings to patients, in addition to the warnings they provide to prescribing physicians regarding the side effects of drugs, even if a drug is advertised directly to patients.